ChartRow logo
Share this page
MMSI
$89.20-0.41%
as of close, Oct 16, 2026
☾ AH $89.20 -0.41%
PeersMRNALLYMDTUNHJNJTMO

MMSI financial statements

The full income statement, balance sheet, and cash-flow statement for Merit Medical Systems Inc. (MMSI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 58.2M2024-09 58.3M2024-12 58.8M2025-03 59.1M2025-06 59.2M2025-09 59.3M2025-12 59.4M2026-03 59.7M2026-06 59.7M+2.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue1.52B+11.8%1.36B+7.9%1.26B+9.2%1.15B+7.1%1.07B+11.5%
738M+14.8%643M+10.2%584M+12.5%519M+7.0%485M+21.0%
Cost of revenue778M+9.0%713M+5.9%673M+6.6%632M+7.2%589M+4.7%
554M+13.5%488M+6.0%460M+6.6%432M+1.7%424M+5.4%
Research & development97.4M+11.3%87.5M+5.7%82.7M+9.6%75.5M+6.0%71.2M+23.8%
Selling, general & administrative455M+13.9%400M+7.0%374M+9.1%343M+2.0%336M+12.8%
Restructuring5.90M+90.3%3.10M+14.8%2.70M-62.5%7.20M—
Amortization of intangibles85.1M+29.7%65.6M+16.9%56.1M+15.9%48.4M-2.4%49.6M-15.4%
Operating income185M+18.6%156M+25.6%124M+41.5%87.6M+43.7%60.9M+3999.9%
Interest expense26.5M-15.2%31.2M+101.3%15.5M+144.7%6.34M+20.5%5.26M-47.4%
Other non-operating income-2.39M-236.4%-711K-159.3%1.20M+24.2%966K+138.5%-2.51M-10.0%
Pre-tax income171M+14.0%150M+33.8%112M+35.7%82.6M+53.3%53.9M+507.5%
Income tax42.4M+43.2%29.6M+67.6%17.7M+117.9%8.11M+48.5%5.46M+261.2%
Net income128M+6.8%120M+27.5%94.4M+26.7%74.5M+53.8%48.5M+592.3%
$2.13+4.9%$2.03+25.3%$1.62+25.6%$1.29+53.6%$0.84+566.7%
EPS (basic)$2.17+4.8%$2.07+26.2%$1.64+25.2%$1.31+52.3%$0.86+577.8%
Weighted-avg shares (basic)59.2M+1.6%58.2M+1.1%57.6M+1.4%56.8M+1.2%56.1M+1.3%
Weighted-avg shares (diluted)60.5M+1.8%59.4M+1.7%58.4M+1.2%57.7M+0.5%57.4M+3.5%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.04B+12.6%924M-16.7%1.11B+109.5%529M+9.7%482M+12.2%
Cash & equivalents446M+18.5%377M-35.8%587M+905.1%58.4M-13.8%67.8M+19.0%
Accounts receivable204M+7.1%190M+6.9%178M+8.0%165M+8.1%152M+3.9%
Inventory334M+9.0%306M+0.7%304M+14.2%266M+19.9%222M+12.1%
Prepaid expenses31.5M+10.3%28.5M+17.5%24.3M+8.8%22.3M+38.2%16.1M+23.1%
2.69B+11.1%2.42B+4.0%2.33B+39.7%1.66B+1.0%1.65B-1.0%
Property, plant & equipment428M+10.9%386M+0.7%384M+0.1%383M+3.0%372M-2.9%
Operating lease right-of-use87.6M+33.7%65.5M+3.9%63.0M-3.4%65.3M-1.0%65.9M-15.8%
Goodwill507M+9.3%464M+21.3%382M+6.2%360M-0.5%362M-0.5%
Deferred tax assets7.05M-56.1%16.0M+120.1%7.29M+10.4%6.60M+8.5%6.08M+32.3%
Other non-current assets78.2M+19.7%65.3M+19.2%54.8M+23.5%44.4M+7.1%41.4M+9.9%
240M+10.8%216M+6.3%204M-7.7%221M-6.6%236M+27.7%
Accounts payable60.6M-11.6%68.5M+3.9%65.9M-3.7%68.5M+23.2%55.6M+11.6%
Accrued liabilities159M+19.0%134M+11.3%120M-2.2%123M-22.5%159M+42.0%
Short-term & current debt———11.3M+33.3%8.44M+12.5%
Current lease liability10.9M+5.3%10.3M-14.5%12.1M+9.8%11.0M+3.2%10.7M-17.3%
1.10B+6.0%1.04B-7.5%1.12B+116.2%520M-14.6%608M-13.8%
Long-term debt734M+0.6%730M-11.4%823M+340.7%187M-20.3%234M-31.8%
Deferred revenue (non-current)1.40M-6.9%1.50M-6.4%1.60M-6.0%1.71M-5.9%1.81M-5.6%
Non-current lease liability76.7M+39.9%54.8M-2.6%56.3M-5.8%59.7M-2.9%61.5M-13.3%
Operating lease liability (total)87.5M+34.4%65.1M-4.7%68.3M-3.4%70.7M-2.0%72.2M-13.9%
Deferred tax liabilities19.7M+8093.8%240K-95.7%5.55M-70.0%18.5M-41.4%31.5M-5.4%
Other non-current liabilities10.3M-33.3%15.5M+11.7%13.8M-6.1%14.7M-37.5%23.6M-55.3%
1.58B+14.9%1.38B+14.8%1.20B+5.0%1.14B+10.1%1.04B+8.5%
Preferred stock0.000.000.000.000.00
Common stock764M+8.6%703M+10.2%638M-5.5%675M+5.2%642M+5.8%
Retained earnings824M+18.5%696M+20.9%575M+19.6%481M+18.3%406M+13.5%
Accumulated other comprehensive income-3.64M+81.3%-19.4M-71.2%-11.3M+1.9%-11.6M-44.5%-7.99M-46.6%
Total liabilities & equity2.69B+11.1%2.42B+4.0%2.33B+39.7%1.66B+1.0%1.65B-1.0%
Common shares issued59.4M+1.2%58.7M+1.5%57.9M+1.0%57.3M+1.3%56.6M+1.7%
Common shares outstanding59.4M+1.2%58.7M+1.5%57.9M+1.0%57.3M+1.3%56.6M+1.7%
Shares outstanding (cover)59.4M+1.0%58.8M+1.6%57.9M+1.1%57.3M+1.3%56.6M+1.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
297M+34.7%221M+52.1%145M+27.0%114M-22.4%147M-10.9%
Depreciation & amortization123M+19.9%103M+14.1%90.0M+10.0%81.8M-2.7%84.1M-10.6%
Intangible amortization85.1M+29.7%65.6M+16.9%56.1M+15.9%48.4M-2.4%49.6M-15.4%
Share-based compensation43.5M+52.6%28.5M+33.5%21.3M+18.2%18.0M+12.1%16.1M+12.2%
Deferred income taxes5.21M+135.1%-14.9M-17.6%-12.6M+15.3%-14.9M-222.3%-4.63M+59.0%
Change in receivables7.34M-46.4%13.7M+14.9%11.9M-21.2%15.1M+75.4%8.62M+182.7%
Change in inventory21.6M+844.6%2.29M-92.9%32.1M-33.0%47.9M+90.3%25.2M+185.6%
-247M+32.9%-369M-110.2%-175M-205.5%-57.4M-54.5%-37.2M+36.6%
Capital expenditure81.7M+132.5%35.1M+2.5%34.3M-23.8%45.0M+61.2%27.9M-39.2%
Free cash flow216M+16.2%186M+67.5%111M+60.1%69.3M-41.9%119M+0.0%
Acquisitions145M-54.8%320M+138.0%135M+1856.7%6.88M-4.1%7.17M-34.5%
Proceeds from sale of PP&E—5.00K-97.5%201K+209.2%65.0K-93.7%1.04M+2369.0%
16.0M+126.7%-60.0M-110.7%559M+1028.1%-60.3M+38.8%-98.4M-2.9%
Long-term debt issued0.000.00-100.0%1.20B+457.2%215M+118.7%98.4M+43.4%
Long-term debt repaid0.000.000.00-100.0%260M+25.7%207M+31.8%
Common stock issued28.2M-31.0%40.9M+162.5%15.6M-22.4%20.1M-5.8%21.3M+221.1%
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
FX effect on cash
————-801K-147.6%
Net change in cash69.8M+133.2%-210M-139.8%529M+7449.6%-7.19M-166.4%10.8M-14.0%
Interest paid21.0M-9.7%23.2M+65.4%14.1M+124.5%6.26M+19.0%5.26M-47.8%
Income taxes paid31.4M-30.3%45.0M+42.9%31.5M+84.5%17.1M+93.6%8.83M-1.0%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap5.24B-7.9%5.69B+29.7%4.39B+9.1%4.02B+14.0%3.52B+14.0%
P/E40.8×-13.8%47.3×+8.0%43.8×-32.8%65.1×-10.5%72.7×
P/S3.5×-17.6%4.2×+17.3%3.6×+1.1%3.5×+7.9%3.3×+2.2%
P/B3.3×-19.9%4.1×+15.7%3.6×-3.4%3.7×+8.9%3.4×+5.1%
P/FCF24.3×-20.7%30.7×-50.2%61.6×+39.7%44.1×+49.1%29.5×+14.0%
Earnings yield2.5%+16.0%2.1%-7.4%2.3%+48.7%1.5%+11.7%1.4%
FCF yield4.1%+26.2%3.3%+100.8%1.6%-28.4%2.3%-32.9%3.4%-12.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: MMSI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MMSI filings on SEC EDGAR → Not investment advice.